314 / 815
RT in Cervix Cancer
•
Definitive/Primary
Bulky IB2/IIA – IVB (PAN only)
Pelvic EBRT (45-50Gy/25-28#) +/- weekly cisplatin
Intra-cavitary brachytherapy (21-28Gy/3-4#)
•
Adjuvant
High Risk - +ve margins/parametrium/LNs (RT+C)
Intermediate Risk – LVSI, stromal invasion, size (RT alone)
45-50.4Gy/25-28# +/- cisplatin
•
Salvage – recurrence following surgery
•
Palliative
Peters (2000)
JCO
Apr; 18(8): 1606-13.
Rotman (2006)
IJROBP May 1; 65(1): 169-76.